ArticleScientific reports2025
Immunoglobulin G dynamics and outcomes of hypogammaglobulinemia in liver transplant recipients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Hypogammaglobulinemia (HGG) is a common complication of liver transplantation (LT). However, the impact of underlying liver disease severity on post-LT immunoglobulin dynamics remains unclear. We aimed to evaluate the differences in serum immunoglobulin G (IgG) levels based on the pre-transplantation model for end-stage liver disease (MELD) scores. We collected data from patients who underwent LT between July 2016 and December 2022 at a tertiary hospital. Propensity score matching was performed between the low and high MELD groups and IgG dynamics were evaluated. The significance of peri-LT HGG on clinical outcomes was also evaluated. In a matched population (1:1 propensity score matching), the median serum IgG levels decreased significantly from 1,606.5 mg/dL pre-LT to 1,011.6 mg/dL 1-month post-LT. IgG levels before and after transplantation (1 month, 6 months, and 1 year) did not differ significantly between the groups. Overall, 36.0% of patients developed HGG within 1 year after transplantation. Multivariable Cox regression analysis showed that pre-LT HGG was independently associated with mortality. In conclusion, HGG is frequent complication in peri-LT period and pre-LT HGG is significantly associated with mortality. No significant difference in HGG according to the MELD score was observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.